David J. Hellerstein, MD

Psychedelic Therapies: One Drug, Multiple Treatments: Reply to Modesto-Lowe et al

September 1, 2025

The authors reply to a letter by Modesto-Lowe et al regarding their survey of psychedelic practitioners’ views on psychological support.

David A. Bender, Sandeep M. Nayak, Joshua S. Siegel, et al

Original Research

Maintenance of Antidepressant Effect After 1 Dose of Psilocybin

March 3, 2025

Over 52 weeks, a single administration of 25 mg psilocybin suggested longer maintenance of antidepressant effect than both 1 mg and 10 mg.

Guy M. Goodwin, Ania Nowakowska, Merve Atli, et al

Original Research

Psychological Support in Psychedelic Therapy

February 5, 2025

The survey reveals differences of opinion among psychedelic researchers, with a slight trend toward preference for an emotive approach to psychological support.

David A. Bender, Sandeep M. Nayak, Joshua S. Siegel, et al

Article

Does Negative Affectivity Predict Differential Response to an SSRI Versus a Non-SSRI Antidepressant?

September 25, 2014

Pierre Blier, Jonathan W. Stewart, Maria Lidia Gerra, et al

Original Research

A Randomized Controlled Trial of Duloxetine Versus Placebo in the Treatment of Nonmajor Chronic Depression

July 15, 2012

Patrick J. McGrath, Jonathan W. Stewart, David J. Hellerstein, et al

Article

Can People With Nonsevere Major Depression Benefit From Antidepressant Medication?

December 27, 2011

Patrick J. McGrath, Jonathan W. Stewart, David J. Hellerstein, et al

Original Research

The Effectiveness of St. John's Wort in Major Depressive Disorder: A Naturalistic Phase 2 Follow-Up in Which Nonresponders Were Provided Alternate Medication

August 1, 2004

David L. Dunner, Michael E. Thase, Richard C. Shelton, et al

Original Research

Venlafaxine in the Treatment of Dysthymia: An Open-Label Study

December 31, 1999

David J. Hellerstein, Sarai T. Batchelder, Suzanne A. S. Little, et al

Letter to the Editor

Early Augmentation of Sertraline With Methylphenidate

February 28, 1999

Richard N. Rosenthal, David J. Hellerstein, Teodor T. Postolache, et al

Psychedelic Therapies: One Drug, Multiple Treatments: Reply to Modesto-Lowe et al

Maintenance of Antidepressant Effect After 1 Dose of Psilocybin

Psychological Support in Psychedelic Therapy

Does Negative Affectivity Predict Differential Response to an SSRI Versus a Non-SSRI Antidepressant?

A Randomized Controlled Trial of Duloxetine Versus Placebo in the Treatment of Nonmajor Chronic Depression

Can People With Nonsevere Major Depression Benefit From Antidepressant Medication?

The Effectiveness of St. John's Wort in Major Depressive Disorder: A Naturalistic Phase 2 Follow-Up in Which Nonresponders Were Provided Alternate Medication

Venlafaxine in the Treatment of Dysthymia: An Open-Label Study

Early Augmentation of Sertraline With Methylphenidate

ELSEWHERE:

FOLLOW US:

David J. Hellerstein, MD

Psychedelic Therapies: One Drug, Multiple Treatments: Reply to Modesto-Lowe et al

Maintenance of Antidepressant Effect After 1 Dose of Psilocybin

Psychological Support in Psychedelic Therapy

Does Negative Affectivity Predict Differential Response to an SSRI Versus a Non-SSRI Antidepressant?

A Randomized Controlled Trial of Duloxetine Versus Placebo in the Treatment of Nonmajor Chronic Depression

Can People With Nonsevere Major Depression Benefit From Antidepressant Medication?

The Effectiveness of St. John's Wort in Major Depressive Disorder: A Naturalistic Phase 2 Follow-Up in Which Nonresponders Were Provided Alternate Medication

Venlafaxine in the Treatment of Dysthymia: An Open-Label Study

Early Augmentation of Sertraline With Methylphenidate

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles